372 related articles for article (PubMed ID: 32903060)
21. Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard.
Schaudinn A; Gawlitza J; Mucha S; Linder N; Franz T; Horn LC; Kahn T; Busse H
Eur J Radiol; 2019 Jul; 116():180-185. PubMed ID: 31153562
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer.
Rudolph MM; Baur ADJ; Cash H; Haas M; Mahjoub S; Hartenstein A; Hamm CA; Beetz NL; Konietschke F; Hamm B; Asbach P; Penzkofer T
Sci Rep; 2020 Sep; 10(1):15982. PubMed ID: 32994502
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Weighted Diffusion Subtraction for Detection of Clinically Significant Prostate Cancer.
Sato T; Isoda H; Fujimoto K; Furuta A; Fujimoto M; Ito K; Kobayashi T; Nakamoto Y
J Magn Reson Imaging; 2021 Dec; 54(6):1979-1988. PubMed ID: 34085328
[TBL] [Abstract][Full Text] [Related]
24. Application of Prostate Imaging Reporting and Data System Version 2 (PI-RADS v2): Interobserver Agreement and Positive Predictive Value for Localization of Intermediate- and High-Grade Prostate Cancers on Multiparametric Magnetic Resonance Imaging.
Chen F; Cen S; Palmer S
Acad Radiol; 2017 Sep; 24(9):1101-1106. PubMed ID: 28546032
[TBL] [Abstract][Full Text] [Related]
25. Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2.
Feng ZY; Wang L; Min XD; Wang SG; Wang GP; Cai J
Chin Med J (Engl); 2016 Oct; 129(20):2451-2459. PubMed ID: 27748338
[TBL] [Abstract][Full Text] [Related]
26. Validation of the Dominant Sequence Paradigm and Role of Dynamic Contrast-enhanced Imaging in PI-RADS Version 2.
Greer MD; Shih JH; Lay N; Barrett T; Kayat Bittencourt L; Borofsky S; Kabakus IM; Law YM; Marko J; Shebel H; Mertan FV; Merino MJ; Wood BJ; Pinto PA; Summers RM; Choyke PL; Turkbey B
Radiology; 2017 Dec; 285(3):859-869. PubMed ID: 28727501
[TBL] [Abstract][Full Text] [Related]
27. Comparison of diagnostic performance and inter-reader agreement between PI-RADS v2.1 and PI-RADS v2: systematic review and meta-analysis.
Lee CH; Vellayappan B; Tan CH
Br J Radiol; 2022 Mar; 95(1131):20210509. PubMed ID: 34520694
[TBL] [Abstract][Full Text] [Related]
28. Assessment of PI-RADS v2 for the Detection of Prostate Cancer.
Kasel-Seibert M; Lehmann T; Aschenbach R; Guettler FV; Abubrig M; Grimm MO; Teichgraeber U; Franiel T
Eur J Radiol; 2016 Apr; 85(4):726-31. PubMed ID: 26971415
[TBL] [Abstract][Full Text] [Related]
29. Effect of observation size and apparent diffusion coefficient (ADC) value in PI-RADS v2.1 assessment category 4 and 5 observations compared to adverse pathological outcomes.
Abreu-Gomez J; Walker D; Alotaibi T; McInnes MDF; Flood TA; Schieda N
Eur Radiol; 2020 Aug; 30(8):4251-4261. PubMed ID: 32211965
[TBL] [Abstract][Full Text] [Related]
30. Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1.
Brembilla G; Dell'Oglio P; Stabile A; Damascelli A; Brunetti L; Ravelli S; Cristel G; Schiani E; Venturini E; Grippaldi D; Mendola V; Rancoita PMV; Esposito A; Briganti A; Montorsi F; Del Maschio A; De Cobelli F
Eur Radiol; 2020 Jun; 30(6):3383-3392. PubMed ID: 32052171
[TBL] [Abstract][Full Text] [Related]
31. Comparison of PI-RADS version 2.1 and PI-RADS version 2 regarding interreader variability and diagnostic accuracy for transition zone prostate cancer.
Xu L; Zhang G; Zhang D; Zhang X; Bai X; Yan W; Zhou Y; Zhou Z; Xiao Y; Jin Z; Sun H
Abdom Radiol (NY); 2020 Dec; 45(12):4133-4141. PubMed ID: 32918577
[TBL] [Abstract][Full Text] [Related]
32. Interobserver Agreement and Accuracy in Interpreting mpMRI of the Prostate: a Systematic Review.
Annamalai A; Fustok JN; Beltran-Perez J; Rashad AT; Krane LS; Triche BL
Curr Urol Rep; 2022 Jan; 23(1):1-10. PubMed ID: 35226257
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Prostate Imaging and Reporting Data System V2.0 and V2.1 for Evaluation of Transition Zone Lesions: A 5-Reader 202-Patient Analysis.
Kim N; Kim S; Prabhu V; Shanbhogue K; Smereka P; Tong A; Anthopolos R; Taneja SS; Rosenkrantz AB
J Comput Assist Tomogr; 2022 Jul-Aug 01; 46(4):523-529. PubMed ID: 35405714
[TBL] [Abstract][Full Text] [Related]
34. Direct comparison of PI-RADS version 2 and version 1 regarding interreader agreement and diagnostic accuracy for the detection of clinically significant prostate cancer.
Becker AS; Cornelius A; Reiner CS; Stocker D; Ulbrich EJ; Barth BK; Mortezavi A; Eberli D; Donati OF
Eur J Radiol; 2017 Sep; 94():58-63. PubMed ID: 28941761
[TBL] [Abstract][Full Text] [Related]
35. Investigating the role of DCE-MRI, over T2 and DWI, in accurate PI-RADS v2 assessment of clinically significant peripheral zone prostate lesions as defined at radical prostatectomy.
Taghipour M; Ziaei A; Alessandrino F; Hassanzadeh E; Harisinghani M; Vangel M; Tempany CM; Fennessy FM
Abdom Radiol (NY); 2019 Apr; 44(4):1520-1527. PubMed ID: 30361870
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic Performance of PI-RADS v2, Proposed Adjusted PI-RADS v2 and Biparametric Magnetic Resonance Imaging for Prostate Cancer Detection: A Preliminary Study.
Cai GH; Yang QH; Chen WB; Liu QY; Zeng YR; Zeng YJ
Curr Oncol; 2021 May; 28(3):1823-1834. PubMed ID: 34065851
[TBL] [Abstract][Full Text] [Related]
37. Validation of dominant and secondary sequence utilization in PI-RADS v2 for classifying prostatic lesions.
Soodana-Prakash N; Castillo RP; Reis IM; Stoyanova R; Kwon D; Velasquez MC; Nahar B; Kannabur P; Johnson TA; Swain SK; Ben-Yakar N; Venkatramani V; Ritch C; Satyanarayana R; Gonzalgo ML; Parekh DJ; Bittencourt L; Punnen S
Can J Urol; 2019 Jun; 26(3):9763-9768. PubMed ID: 31180306
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the size criterion for PI-RADSv2 category 5 upgrade: is 15 mm the best threshold?
An JY; Harmon SA; Mehralivand S; Czarniecki M; Smith CP; Peretti JA; Wood BJ; Pinto PA; Choyke PL; Shih JH; Turkbey B
Abdom Radiol (NY); 2018 Dec; 43(12):3436-3444. PubMed ID: 29752491
[TBL] [Abstract][Full Text] [Related]
39. [The diagnostic value of version 2.1 prostate imaging reporting and data system for prostate transitional zone lesions].
Yang S; Zhang CY; Zhang YY; Tan SX; Wei CG; Shen XH; Shen JK
Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(45):3609-3613. PubMed ID: 33333685
[No Abstract] [Full Text] [Related]
40. Diagnostic Performance and Interobserver Consistency of the Prostate Imaging Reporting and Data System Version 2: A Study on Six Prostate Radiologists with Different Experiences from Half a Year to 17 Years.
Ke Z; Wang L; Min XD; Feng ZY; Kang Z; Zhang PP; Li BS; You HJ; Hou SC
Chin Med J (Engl); 2018 Jul; 131(14):1666-1673. PubMed ID: 29998885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
